Clinical Trials on Meningococcal Vaccines in Taiwan

Total 35 results

Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered to Infants in Taiwan

Vaccines | Pneumococcal Conjugate Vaccine

Taiwan
GlaxoSmithKline
Novartis Vaccines

Completed

Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Meningococcal B Recombinant Vaccine When Administered Concomitantly With Routine Vaccines to Healthy Infants of 2 Months of Age and Older, in Taiwan.

Meningococcal Disease | Infections, Meningococcal

Taiwan
GlaxoSmithKline

Completed

Co-administration of Meningococcal Vaccine GSK134612 and Pneumococcal Vaccine GSK1024850A vs Individual Administration

Infections, Meningococcal

Taiwan, Mexico
GlaxoSmithKline

Completed

Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 11-17 Year-Old Subjects

Infections, Meningococcal

Taiwan, Philippines, India
Chimei Medical Center

Completed

Sonography for COVID-19 Vaccines Related Reactive Lymphadenopathy

Reactive Axillary Lymphadenopathy for SARS-CoV-2 Vaccines in the Asian Taiwanese Population

Taiwan
Taipei Medical University Shuang Ho Hospital

Unknown

Using "Decision Aids" to Help the Infant Family to Decide the Use of Oral Rotavirus Vaccine

Rotavirus Vaccines

Taiwan
National Cheng-Kung University Hospital

Unknown

The Effect and Safety of the Seasonal Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Not on Dialysis

Chronic Kidney Disease | Immunogenicity and Adverse Drug Effect of Vaccines Influenza

Taiwan
Medigen Vaccine Biologics Corp.

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of COVID-19 Vaccine, CT-COV-21 Extension Study

Covid19 Vaccine

Taiwan
Medigen Vaccine Biologics Corp.

Completed

A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult (COVID-19)

Covid19 Vaccine

Taiwan, Vietnam
National Taiwan University Hospital
Ministry of Science and Technology, Taiwan; Academia Sinica, Taiwan

Recruiting

The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort (IRHBRVD)

Hepatitis B | Vaccination; Infection | Preventable Disease, Vaccine

Taiwan
Centers for Disease Control, Taiwan
Public Health Bureau,Taoyan County Governmnet, Taiwan; Education Department...

Completed

Evaluation of a School-based Influenza Vaccination Program

Influenza | Influenza Vaccines

Taiwan
National Taiwan University Hospital

Unknown

Antibody Response and Immune Memory 15-18 Years After HBV Vaccination

Hepatitis B | Vaccine

Taiwan
GlaxoSmithKline

Completed

Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults

Influenza | Influenza Vaccines

Taiwan, Hong Kong, Thailand, Singapore
National Taiwan University Hospital

Recruiting

Influenza Vaccine Effectiveness in Among Young Children in Taiwan

Influenza Vaccine Allergy

Taiwan
Medigen Vaccine Biologics Corp.

Completed

A Study to Evaluate the Safety and Immunogenicity of H7N9 Influenza Vaccine (AT-501) in Healthy Adult Subjects

H7N9 Influenza Vaccine

Taiwan
National Taiwan University Hospital

Completed

A Heterologous Prime-boost Study to Evaluate Immunogenicity and Safety of mRNA-1273 With MVC-COV1901 in Adults

Covid19 Vaccine

Taiwan
Medigen Vaccine Biologics Corp.

Completed

A Study o Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901, CT-COV-21 Sub-study

Covid19 Vaccine

Taiwan
Taoyuan General Hospital
Medigen Vaccine Biologics Corp.

Recruiting

A Heterologous 3rd COVID-19 Vaccine of MVC-COV1901 to Evaluate Immunogenicity and Safety in Adults With ChAdOx1-nCov-19

COVID-19 Vaccine

Taiwan
Medigen Vaccine Biologics Corp.

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901 or MVC-COV1901(Beta) Against COVID-19

COVID-19 Vaccine

Taiwan
Medigen Vaccine Biologics Corp.

Completed

A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adolescents

Covid19 Vaccine

Taiwan
Chang Gung Memorial Hospital

Recruiting

Immunogenicity of COVID-19 Vaccine on Heterologous Schedule

Healthy | Covid-19 | Vaccine | Immunogenicity | Reactogenicity

Taiwan
Medigen Vaccine Biologics Corp.
Coalition for Epidemic Preparedness Innovations

Completed

A Study to Evaluate the Safety and Immunogenicity of Booster With AZD1222, mRNA-1273, or MVC-COV1901 Against COVID-19

COVID-19 Vaccine

Taiwan
Novartis
Novartis Vaccines

Completed

Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants

Meningitis | Meningococcal Infection

United States, China, Costa Rica, Guatemala, Panama, Peru
GlaxoSmithKline

Completed

Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects.

Infections, Papillomavirus | Papillomavirus Vaccines

Germany, Taiwan, Colombia, Panama, Honduras
Medigen Vaccine Biologics Corp.

Completed

A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Elderly Adults

Covid19 Vaccine

Taiwan
National Taiwan University Hospital

Completed

Effectiveness of Booster With 1 or 2 Doses of HAV Vaccine Among HIV-infected Patients

Hepatitis A | Human Immunodeficiency Virus | Vaccine Response Impaired

Taiwan
GlaxoSmithKline

Completed

Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks

Infections, Rotavirus | Rotavirus Vaccines

United States, Finland, Germany, Taiwan, Spain, Costa Rica, Korea, Republic of, Japan
Shanxi Medical University
Centers for Disease Control and Prevention, China

Not yet recruiting

Immunogenicity and Persistence of Hepatitis B Vaccination in Methadone Maintenance Treatment Patients

Hepatitis B Vaccine

China
Shanxi Medical University
Centers for Disease Control and Prevention, China

Not yet recruiting

Immunogenicity and Persistence of Hepatitis B Vaccination in HIV-Infected Patients

Hepatitis B Vaccine

China
Hepatopancreatobiliary Surgery Institute of Gansu...
The First Affiliated Hospital of Anhui Medical University; LanZhou University; Beijing YouAn Hospital and other collaborators

Completed

Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)

COVID-19 | Vaccine Reaction | Liver Disease

China
Huashan Hospital
LanZhou University; The Affiliated Hospital of Qingdao University; The Second... and other collaborators

Recruiting

Safety and Immunogenicity of COVID-19 Vaccine Booster in Patients With Liver Diseases (NMCIDCHESS2201)

Liver Diseases | COVID-19 | Vaccine Reaction

China
GlaxoSmithKline

Completed

Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and Older

Herpes Zoster | Herpes Zoster Vaccine

United States, Australia, Spain, Finland, Germany, Japan, Taiwan, Canada, Sweden, Korea, Republic of, Czechia, Hong Kong, Mexico, Italy, Brazil, Estonia, France, United Kingdom
Jennerex Biotherapeutics

Completed

A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib (TRAVERSE)

HCC | Hepatocellular Carcinoma | Liver Cancer

Korea, Republic of, United States, Hong Kong, Canada, Germany, France, Taiwan
SillaJen, Inc.

Completed

Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone (PHOCUS)

Hepatocellular Carcinoma (HCC)

United States, Canada, New Zealand, Australia, China, France, Germany, Hong Kong, Israel, Italy, Korea, Republic of, Portugal, Singapore, Taiwan, Thailand, United Kingdom
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age

Measles; Mumps; Rubella | Measles-Mumps-Rubella Vaccine

United States, Finland, Taiwan, Estonia, Puerto Rico

Clinical Trials on Meningococcal Vaccines in Taiwan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations